Deferasirox dispersible tablets

Details for Australian Patent Application No. 2009201696 (hide)

Owner Novartis AG

Inventors Cassiere, Jean-Pierre; Beauchamp, Catherine; Battung, Florian

Agent Davies Collison Cave

Pub. Number AU-A-2009201696

Parent 2005230402

Filing date 28 April 2009

Wipo publication date 21 May 2009

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

Event Publications

21 May 2009 Application Open to Public Inspection

  Published as AU-A-2009201696

21 May 2009 Complete Application Filed

3 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009201697-Auger for vertical mixer

2009201695-System for permitting control of the purging of a node B by the serving radio network controller